I

Immuneering Corp
D

IMRX

2.05000
USD
0.02
(0.99%)
مفتوح الان
حجم التداول
737
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
63,653,418
أصول ذات صلة
    ABBV
    ABBV
    -4.630
    (-2.73%)
    183.470 USD
    AMGN
    AMGN
    -12.22
    (-4.13%)
    280.50 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    156.550 USD
    LLY
    LLY
    -40.34
    (-5.13%)
    792.68 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    103.270 USD
    NVS
    NVS
    -0.350
    (-0.34%)
    105.180 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.880 USD
    المزيد
الأخبار

العنوان: Immuneering Corp

القطاع: Healthcare
الصناعة: Biotechnology
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.